IRIS
FRANZE', Maria Stella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.825
NA - Nord America 1.677
AS - Asia 861
SA - Sud America 239
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 37
OC - Oceania 3
Totale 4.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.614
RU - Federazione Russa 1.014
SG - Singapore 324
IT - Italia 275
CN - Cina 230
BR - Brasile 192
IE - Irlanda 170
SE - Svezia 93
HK - Hong Kong 83
DE - Germania 73
VN - Vietnam 52
IN - India 49
FR - Francia 36
GB - Regno Unito 35
CA - Canada 31
PL - Polonia 30
BD - Bangladesh 28
FI - Finlandia 22
AR - Argentina 19
AT - Austria 18
NL - Olanda 16
ID - Indonesia 13
JP - Giappone 12
ZA - Sudafrica 12
UZ - Uzbekistan 11
MX - Messico 10
PK - Pakistan 10
TR - Turchia 9
CO - Colombia 7
IL - Israele 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
BE - Belgio 5
GT - Guatemala 5
AE - Emirati Arabi Uniti 4
EE - Estonia 4
ES - Italia 4
IQ - Iraq 4
MA - Marocco 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
SV - El Salvador 3
TN - Tunisia 3
AU - Australia 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
GP - Guadalupe 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
TZ - Tanzania 1
UA - Ucraina 1
UY - Uruguay 1
Totale 4.643
Salva come PNG Salva come JPEG
Città #
Ashburn 326
Moscow 291
Dallas 175
Singapore 172
Dublin 170
San Jose 134
Chandler 106
Messina 102
Hong Kong 82
Nyköping 66
Council Bluffs 49
The Dalles 48
Beijing 44
Munich 36
Los Angeles 32
New York 31
Warsaw 28
Lauterbourg 22
Santa Clara 20
Hyderabad 19
São Paulo 18
Tianjin 18
Phoenix 16
Redondo Beach 16
Princeton 15
Orem 14
Avola 13
Catania 13
Hanoi 13
Medford 13
Nuremberg 13
Amsterdam 12
Buffalo 12
Ann Arbor 11
Frankfurt am Main 11
Tokyo 11
Des Moines 10
Vienna 10
Atlanta 9
Brooklyn 9
Columbus 9
Dearborn 9
Helsinki 9
Tashkent 9
Jakarta 8
Montreal 8
Rome 8
Shanghai 8
Chennai 7
Denver 7
Ho Chi Minh City 7
Jacksonville 7
Johannesburg 7
Lawrenceville 7
Milan 7
North Bergen 7
Rio de Janeiro 7
Turku 7
Guangzhou 6
Haiphong 6
Pune 6
Stockholm 6
Brasília 5
Brussels 5
Guatemala City 5
Islamabad 5
Lappeenranta 5
Mexico City 5
New Delhi 5
Pachino 5
San Francisco 5
Seattle 5
Shenzhen 5
Sorocaba 5
Baghdad 4
Boardman 4
Bremen 4
Cambridge 4
Dong Ket 4
Houston 4
Jinan 4
London 4
Nanjing 4
Poplar 4
Tel Aviv 4
Turin 4
Abidjan 3
Amman 3
Barnet 3
Belo Horizonte 3
Campinas 3
Cape Town 3
Charlotte 3
Curitiba 3
Da Nang 3
Dhaka 3
Esmeraldas 3
Fino Mornasco 3
Haikou 3
Lahore 3
Totale 2.522
Salva come PNG Salva come JPEG
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 285
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 283
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 270
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 226
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 209
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 205
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 200
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 183
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 181
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 178
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 175
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 172
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 172
Monofocal hepatocellular carcinoma: How much does size matter? 166
Pattern of macrovascular invasion in hepatocellular carcinoma 157
Natural course of COVID-19 and independent predictors of mortality 156
Characterization of the intrahepatic immune microenvironment and gene expression profile in hepatitis B and hepatocellular carcinoma 156
The changing scenario of hepatocellular carcinoma in Italy: an update 153
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 147
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 131
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 127
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 126
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 116
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 115
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 110
Hepatitis Delta Virus and Hepatocellular Carcinoma 108
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 90
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 83
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression 38
null 20
Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy 18
Totale 4.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022105 0 0 0 0 7 6 17 1 4 16 19 35
2022/2023419 23 48 16 28 29 38 7 24 190 3 12 1
2023/2024145 7 16 3 16 9 30 0 10 1 30 4 19
2024/2025887 5 27 30 50 94 51 66 151 182 57 78 96
2025/20262.539 138 168 193 174 200 478 289 307 338 141 64 49
2026/2027507 73 178 90 153 13 0 0 0 0 0 0 0
Totale 4.756